作为EGFR通路的负调节者,D-cbl对于Drosophila oogenesis的背中中心模式是必需的
L M Pai1, G Barcelo, T Schüpbach
1Howard Hughes Medical Institute, Department of Molecular Biology, Princeton University, New Jersey 08544, USA.
Cell
|October 29, 2000
概括
在D-cbl的突变导致Drosophila oogenesis期间表皮生长因子受体 (EGFR) 途径的过度激活. 这突出了EGFR信号传递的双重控制,需要连接体激活和D-cbl抑制才能适当地确定细胞命运.
科学领域:
- 发展生物学 发展生物学
- 细胞信号传递 细胞信号传递
- 遗传学 是一个遗传学.
背景情况:
- 在Drosophila oogenesis期间Gurken的不对称局部化触发了表皮生长因子受体 (EGFR) 途径.
- EGFR信号传递对于指定背毛囊细胞命运至关重要.
研究的目的:
- 研究D-cbl在Drosophila oogenesis期间调节EGFR活性中的作用.
- 了解控制EGFR信号传递的机制,以精确确定毛囊细胞命运.
主要方法:
- 在Drosophila中使用了马赛克毛囊细胞系统.
- 鉴定并分析了D-cbl基因中的突变.
- 研究了对EGFR激活的依赖性.
主要成果:
- 在D-cbl的突变导致EGFR通路的过度激活.
- 异常的EGFR激活取决于连接体的存在.
- D-cbl 负面调节了EGFR活动.
结论:
- 精确调节EGFR活动需要局部连体激活和D-cbl介导的抑制.
- D-cbl确保了腹囊细胞中EGFR信号的缺失,补充了Gurken的局部激活.
- 这种双重控制机制对于确定不同毛囊细胞命运至关重要.
相关概念视频
Enzyme-linked Receptors
64.6K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
64.6K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Amplifying Signals via Enzymatic Cascade
15.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K
GPCR Desensitization
6.1K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
Transducer Mechanism: G Protein–Coupled Receptors
9.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
9.0K


